Bayer Aktiengesellschaft (BAYRY) News
Track canonical SquawkNews coverage tagged to BAYRY, Bayer Aktiengesellschaft. This hub brings together deduplicated headlines about otc markets otcqx, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Bayer Affirms FY2026 currency-adjusted Adj EPS Guidance of $1.20-$1.35 vs $1.25 Est; Affirms FY2026 currency-adjusted Sales Guidance of $52.
Bayer (OTC: BAYRY ) affirms FY2026 currency-adjusted Adj EPS guidance from $1.20-$1.35 to $1.20-$1.35 vs $1.25 analyst estimate. Affirms FY2026 currency-adjusted sales outlook from $52.109 billion-$54.451 billion to $52.
EARNINGS | Aug 04, 2026, 07:58 AM UTC
L
Bayer, Henry Ford Health partner to expand access to clinical trials
Bayer, Henry Ford Health partner to expand access to clinical trials
EQUITY | Jul 17, 2026, 12:36 PM UTC
H
Bayer Wins Roundup Case
Bayer wins Supreme Court case limiting thousands of state lawsuits over claims that Roundup's active ingredient causes cancer
EQUITY | Jun 26, 2026, 08:12 AM UTC
H
Bayer Wins Roundup Ruling
US Supreme Court rules in favor of Bayer to limit state-court lawsuits claiming Roundup causes cancer
EQUITY | Jun 25, 2026, 02:04 PM UTC